Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a paediatric severity score to predict outcomes of radiographic-confirmed community-acquired pneumonia in hospitalised children in Sabah, Malaysia.

Archives of disease in childhood·2026
Same author

A workforce enhancement model for Australian remote community Primary Health Care services: implementation of a stepped-wedge cluster randomised trial (SW-CRT).

BMC health services research·2026
Same author

Clinical Profile Identification of Indigenous Infants With Bronchiolitis Through Using Unsupervised Feature Extraction and Clustering.

Pediatric pulmonology·2026
Same author

Factors Associated With In-Hospital and Postdischarge Adverse Outcomes Among Children Hospitalized With Community-Acquired Pneumonia in Sabah, Malaysia: A Prospective Cohort Study.

Pediatric pulmonology·2025
Same author

Association between hospitalised childhood pneumonia and follow-up chest radiographs in high-risk populations: a secondary analysis of a multicentre randomised controlled trial.

Archives of disease in childhood·2025
Same author

A peek into the pipeline: Expert views on emerging therapies.

Cell reports. Medicine·2025

Related Experiment Video

Updated: May 12, 2026

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

A cough algorithm for chronic cough in children: a multicenter, randomized controlled study.

Anne Bernadette Chang1, Colin Francis Robertson, Peter Paul van Asperen

  • 1Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia. annechang@ausdoctors.net

Pediatrics
|April 24, 2013
PubMed
Summary
This summary is machine-generated.

A standardized clinical pathway for pediatric chronic cough significantly improved cough resolution and quality of life in children. Early implementation of this cough algorithm demonstrated superior clinical outcomes compared to delayed use.

Keywords:
childrencoughguidelinesrandomized controlled trial

More Related Videos

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
05:43

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

Published on: January 10, 2025

Related Experiment Videos

Last Updated: May 12, 2026

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
05:43

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

Published on: January 10, 2025

Area of Science:

  • Pediatric Pulmonology
  • Clinical Trial Methodology
  • Health Outcomes Research

Background:

  • Chronic cough in children is a common and often persistent issue.
  • Standardized management pathways can potentially improve care efficiency and effectiveness.
  • Evaluating the reliability and validity of such pathways is crucial for clinical adoption.

Purpose of the Study:

  • To evaluate if a standardized clinical management pathway improves clinical outcomes for chronic cough in children within 6 weeks.
  • To assess the reliability and validity of this standardized pathway for pediatric chronic cough.

Main Methods:

  • A pragmatic, multicenter randomized controlled trial involving 272 children with chronic cough.
  • Children were allocated to either early or delayed use of a standardized cough algorithm.
  • Primary outcomes included cough resolution and cough-specific quality of life at 6 weeks.

Main Results:

  • Significantly higher cough resolution rates at 6 weeks in the early-arm group (24.7% absolute risk reduction).
  • Improved cough-specific quality of life scores at 6 weeks in the early-arm group.
  • Shorter cough duration post-randomization and high reliability (κ = 1) and validity (93%-100%) of the algorithm were observed.

Conclusions:

  • Management of pediatric chronic cough using a standardized algorithm improves clinical outcomes.
  • The standardized algorithm is reliable, valid, and feasible for primary care settings.
  • Further validation of this clinical algorithm in diverse settings is recommended.